Akero Therapeutics Inc (AKRO)
29.76
-1.21
(-3.91%)
USD |
NASDAQ |
Nov 14, 16:00
29.02
-0.74
(-2.49%)
After-Hours: 20:00
Akero Therapeutics Cash from Operations (Quarterly): -70.42M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -70.42M |
| June 30, 2024 | -57.45M |
| March 31, 2024 | -35.14M |
| December 31, 2023 | -48.63M |
| September 30, 2023 | -49.72M |
| June 30, 2023 | -22.39M |
| March 31, 2023 | -24.63M |
| December 31, 2022 | -25.51M |
| September 30, 2022 | -24.62M |
| June 30, 2022 | -19.51M |
| March 31, 2022 | -22.88M |
| December 31, 2021 | -26.70M |
| September 30, 2021 | -14.61M |
| June 30, 2021 | -20.03M |
| Date | Value |
|---|---|
| March 31, 2021 | -18.35M |
| December 31, 2020 | -23.40M |
| September 30, 2020 | -13.51M |
| June 30, 2020 | -22.58M |
| March 31, 2020 | -11.32M |
| December 31, 2019 | -11.65M |
| September 30, 2019 | -13.21M |
| June 30, 2019 | -5.322M |
| March 31, 2019 | -5.444M |
| December 31, 2018 | -2.075M |
| September 30, 2018 | -1.961M |
| June 30, 2018 | -0.251M |
| March 31, 2018 | -0.338M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-70.42M
Minimum
Sep 2024
-11.32M
Maximum
Mar 2020
-28.15M
Average
-23.14M
Median
Cash from Operations (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | -66.98M |
| 89bio Inc | -145.36M |
| NovaBay Pharmaceuticals Inc | -2.061M |
| Palatin Technologies Inc | -6.472M |
| iBio Inc | -4.854M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 73.07M |
| Cash from Financing (Quarterly) | 3.067M |
| Free Cash Flow | -212.64M |
| Free Cash Flow Per Share (Quarterly) | -1.014 |
| Free Cash Flow Yield | -11.27% |